TOK-8801

TOK-8801 is a synthesized dihydroimidazothiazole carboxamide and is under development as an immunomodulator.

Product Specifications

CAS Number

[105963-46-0]

UNSPSC

12352005

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/TOK-8801.html

Solubility

10 mM in DMSO

Smiles

O=C(C1=C(C)N2C(S1)=NC(C)(C)C2)NCCC3=CC=CC=C3

Molecular Formula

C17H21N3OS

Molecular Weight

315.43

References & Citations

[1]Fujiwara M, et al. Immunomodulatory activity of the newly synthesized compound TOK-8801 (N- (2-phenylethyl) -3,6,6-trimethyl-5,6-dihydroimidazo[2,1-b]thiazole-2- carboxamide) . Jpn J Pharmacol. 1989 Dec;51 (4) :549-54.|[2]Shibata K, et al. Immunomodulatory effect of a newly synthesized compound, TOK-8801 (N- (2-phenylethyl) -3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type hypersensitivity in mice. Int J Immunopharmacol. 1990;12 (5) :497-502.